Major owner of Exagen Inc. was just granted 9,000 options

James L Tullis, a major owner of Exagen Inc. and a director of the company, just received 9,000 options from the company. The strike price of the options received was $16.41, and these expire on June 16, 2031. Tullis now owns at least 9,000 options on the company.

Some additional info was provided as follows:

The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

The above information was disclosed in a filing to the SEC. To see the filing , click here.

To receive a free e-mail notification whenever Exagen Inc. makes a similar move, sign up!

Auto Refresh